| Literature DB >> 35992596 |
Weiwei Zhang1,2, Gaoxiang Shi1,2, Hui Wang1,2, Miaomiao Feng1,2, Xiang Gao1,2, Qipeng Xie1,2, Ning Zhang1,2, Zhigan Lv1,2.
Abstract
To investigate the molecular mechanism of Xingnao Kaiqiao Pill in the treatment of perioperative neurocognitive disorder (PND) from the perspective of network pharmacology and molecular docking technology. Active ingredients of Xingnao Kaiqiao Pill were screened from the traditional Chinese medicine database and analysis platform, and the putative targets were predicted. The GeneCards database was searched to obtain PND-related targets. The genes corresponding to the targets were searched and annotated on the UniProt database. The VennDiagram package in R was employed to obtain common target genes. The overlap genes were introduced into STRING to obtain a protein-protein interaction (PPI) network; thus, key targets were screened. The target relationship network of "Xingnao Kaiqiao Pill-traditional Chinese medicine-compound-common target" was constructed by Cytoscape software. Using R language package Bioconductor, Gene Ontology (GO) and pathway enrichment analysis (Kyoto Encyclopedia of Genes and Genomes Pathway, KEGG Pathway) were performed on the common target genes. A total of 45 active ingredients of Xingnao Kaiqiao Pill were screened, with 182 potential targets, and 1,579 PND-related targets were retrieved from the GeneCards databases (Score ≥ 1). Using VennDiagram, 132 overlap genes were gotten. Xingnao Kaiqiao Pill mainly acted on targets, such as MAPK and JUN. GO enrichment analysis displayed G protein-coupled amine receptor activity, nuclear receptor activity, ligand-activated transcription factor activity, G protein-coupled neurotransmitter receptor activity, steroid hormone receptor activity, and cytokine receptor activity. KEGG enrichment analysis exhibited 157 signaling pathways. The regulation of interleukin 17, tumor necrosis factor, hypoxia-inducible factor-1, and MAPK signaling pathways affected central nervous system (CNS) inflammatory response, cellular immunity, tumor-related signaling pathways, protected neurons, and inhibited PND. The active ingredients of Xingnao Kaiqiao Pill adjust interleukin 17, tumor necrosis factor, hypoxia-inducible factor-1, and MAPK signaling pathways by acting on cell targets, such as JUN, MAPK, AKT1, etc., and finally exert a therapeutic effect on PND.Entities:
Keywords: drug targets; inflammatory factors; molecular docking; network pharmacology; perioperative neurocognitive disorder
Year: 2022 PMID: 35992596 PMCID: PMC9384889 DOI: 10.3389/fnagi.2022.925072
Source DB: PubMed Journal: Front Aging Neurosci ISSN: 1663-4365 Impact factor: 5.702
Information of ingredients in Xingnao Kaiqiao Pill and their putative targets.
| Chinese name | Latin name | Compound number | Predict target number |
| Banxia |
| 12 | 172 |
| Changpu |
| 4 | 103 |
| Danxing |
| 6 | 81 |
| Gualou |
| 10 | 35 |
| Huanglian |
| 11 | 285 |
| Niuhuang |
| 5 | 18 |
| Yuanzhi |
| 1 | 4 |
Single Chinese medicine with repeated targets.
| Mol ID | Single Chinese medicine | Predict target number |
| MOL000358 |
| 38 |
| MOL000449 |
| 31 |
| MOL000953 |
| 4 |
| MOL003578 |
| 1 |
FIGURE 1The Venn diagram of intersection targets.
FIGURE 2Xingnao Kaiqiao Pill- tradition Chinese medicine—compound-common target relationship network.
FIGURE 3PPI network visualization and analysis. (A) PPI network. (B) The top 10 genes of Degree algorithm. (C) The top 10 genes of Betweeness algorithm. (D) The top 10 genes of Closeness algorithm. (E) The top 10 genes of MCC algorithm.
Analysis of PPI network results.
| Symbol | Degree |
| JUN | 30 |
| MAPK1 | 28 |
| AKT1 | 23 |
| RELA | 22 |
| IL6 | 22 |
| FOS | 21 |
| ESR1 | 20 |
| MAPK14 | 20 |
| MAPK8 | 18 |
| EGFR | 15 |
FIGURE 4GO enrichment analysis of intersection genes. (A) Barplot. (B) Dotplot.
FIGURE 5KEGG enrichment analysis of intersection genes. (A) Barplot. (B) Dotplot.
FIGURE 6The AGE-RAGE signaling pathway.
FIGURE 8The IL-17 signaling pathway.
FIGURE 9Detailed target-compound interactions with the highest molecular docking affinities. (A) The binding pattern between JUN and kaempferol. (B) The binding pattern between AKT1 and beta-sitosterol. (C) The binding pattern between RELA and beta-sitosterol. (D) The binding pattern between MAPK1 and stigmasterol. (E) The binding pattern between IL6 and stigmasterol.
Docking scores of the active ingredients of Xingnao Kaiqiao Pill with their potential targets.
| Molecular name | Affinity (kcal/mol) | ||||
|
| |||||
| JUN | MAPK1 | AKT1 | RELA | IL6 | |
| Stigmasterol | –4.67 | –8.44 | –10.96 | –7.11 | –9.00 |
| Quercetin | –3.81 | –6.58 | –7.49 | –6.37 | –6.96 |
| Beta-sitosterol | –3.32 | –7.59 | –11.00 | –7.18 | –8.19 |
| Kaempferol | –4.12 | –6.76 | –7.71 | –6.50 | –7.45 |
| Baicalein | –3.16 | –6.74 | –6.12 | –6.54 | –6.78 |
*No hydrogen bonds formed.